Dendreon Corp fka DNDNQ

[DrBengtP]

Knowing this is old news (a prospectus from 11/28/05), I still missed a reference to yesterday's IV messages on the cox-regression being pre-specified. However, I found the following by googling, and according to this, a PRESPECIFIED Cox analysis was used.

Just in case anyone would like to see it directly from a company SEC filing.

And, Walldiver, Rancherho, Ocyan and others, thanks for posting here and on the IV board.

Br.
Bengt


SEC File 333-127521 · Accession Number 1193125-5-232799

A pre-specified Cox multivariate regression analysis, which adjusts for prognostic factors known to influence survival, was used to test the validity of the survival benefit seen in this study. Those results showed that patients who received placebo had a relative risk of dying more than twice as high as that of patients who received Provenge (p-value = 0.002, adjusted hazard ratio = 2.1).